207 related articles for article (PubMed ID: 19922476)
1. Searching for the right outcome? A systematic review and meta-analysis of controlled trials using carotid intima-media thickness or pulse wave velocity to infer antiatherogenic properties of thiazolidinediones.
Webb DR; Davies MJ; Gray LJ; Abrams KR; Srinivasan B; Das S; Taub N; Lawrence I; Sutton S; Khunti K
Diabetes Obes Metab; 2010 Feb; 12(2):124-32. PubMed ID: 19922476
[TBL] [Abstract][Full Text] [Related]
2. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Lonn EM; Gerstein HC; Sheridan P; Smith S; Diaz R; Mohan V; Bosch J; Yusuf S; Dagenais GR;
J Am Coll Cardiol; 2009 Jun; 53(22):2028-35. PubMed ID: 19477351
[TBL] [Abstract][Full Text] [Related]
3. Carotid intima-media thickness and brachial-ankle pulse wave velocity in patients with and without coronary artery disease.
Kasliwal RR; Bansal M; Bhargava K; Gupta H; Tandon S; Agrawal V
Indian Heart J; 2004; 56(2):117-22. PubMed ID: 15377132
[TBL] [Abstract][Full Text] [Related]
4. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
[TBL] [Abstract][Full Text] [Related]
5. Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?
Stein EA
J Am Coll Cardiol; 2008 Dec; 52(25):2206-9. PubMed ID: 19095140
[No Abstract] [Full Text] [Related]
6. A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.
Stocker DJ; Taylor AJ; Langley RW; Jezior MR; Vigersky RA
Am Heart J; 2007 Mar; 153(3):445.e1-6. PubMed ID: 17307426
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.
Hedblad B; Zambanini A; Nilsson P; Janzon L; Berglund G
J Intern Med; 2007 Mar; 261(3):293-305. PubMed ID: 17305652
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity.
Yamasaki Y; Katakami N; Furukado S; Kitagawa K; Nagatsuka K; Kashiwagi A; Daida H; Kawamori R; Kaku K
J Atheroscler Thromb; 2010 Nov; 17(11):1132-40. PubMed ID: 20686324
[TBL] [Abstract][Full Text] [Related]
9. Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials.
Bedi US; Singh M; Singh PP; Bhuriya R; Bahekar A; Molnar J; Khosla S; Arora R
J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):268-73. PubMed ID: 20472815
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
Hiukka A; Westerbacka J; Leinonen ES; Watanabe H; Wiklund O; Hulten LM; Salonen JT; Tuomainen TP; Yki-Järvinen H; Keech AC; Taskinen MR
J Am Coll Cardiol; 2008 Dec; 52(25):2190-7. PubMed ID: 19095138
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of rate of change in carotid intima-media thickness by lipid-modifying drugs: impact on clinical outcomes.
Peters SA; den Ruijter HM; Bots ML
Am J Cardiovasc Drugs; 2011 Aug; 11(4):253-63. PubMed ID: 21657803
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity.
Yokoyama H; Aoki T; Imahori M; Kuramitsu M
Kidney Int; 2004 Jul; 66(1):448-54. PubMed ID: 15200455
[TBL] [Abstract][Full Text] [Related]
13. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
Mazzone T; Meyer PM; Feinstein SB; Davidson MH; Kondos GT; D'Agostino RB; Perez A; Provost JC; Haffner SM
JAMA; 2006 Dec; 296(21):2572-81. PubMed ID: 17101640
[TBL] [Abstract][Full Text] [Related]
14. Relationship between carotid intima-media thickness and carotid artery stiffness assessed by ultrafast ultrasound imaging in patients with type 2 diabetes.
Pan FS; Xu M; Yu L; Luo J; Li MY; Liang JY; Zheng YL; Xie XY
Eur J Radiol; 2019 Feb; 111():34-40. PubMed ID: 30691662
[TBL] [Abstract][Full Text] [Related]
15. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
[TBL] [Abstract][Full Text] [Related]
16. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
Pinelli NR; Cha R; Brown MB; Jaber LA
Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
[TBL] [Abstract][Full Text] [Related]
17. Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis.
Labreuche J; Deplanque D; Touboul PJ; Bruckert E; Amarenco P
Atherosclerosis; 2010 Sep; 212(1):9-15. PubMed ID: 20457452
[TBL] [Abstract][Full Text] [Related]
18. The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus.
Polonsky T; Mazzone T; Davidson M
Trends Cardiovasc Med; 2009 Apr; 19(3):94-9. PubMed ID: 19679266
[TBL] [Abstract][Full Text] [Related]
19. Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
Joya-Galeana J; Fernandez M; Cervera A; Reyna S; Ghosh S; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
Diabetes Metab Res Rev; 2011 May; 27(4):373-82. PubMed ID: 21309063
[TBL] [Abstract][Full Text] [Related]
20. Effects of sources of variability on sample sizes required for RCTs, applied to trials of lipid-altering therapies on carotid artery intima-media thickness.
Gould AL; Koglin J; Bain RP; Pinto CA; Mitchel YB; Pasternak RC; Sapre A
Clin Trials; 2009 Aug; 6(4):305-19. PubMed ID: 19667027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
